Pacific Biosciences：情況只會變得更糟 (NASDAQ:PACB)
· seekingalpha.com
Pacific Biosciences 公布第二季營收為 3,901 萬美元，低於市場預期，並下修了 2026 年營收指引，低於市場共識。閱讀為何 PACB 股票評等為賣出。
After the bell on Wednesday, we received second quarter results from Pacific Biosciences ( PACB ). The sequencing solutions company has been one of the most dis...